DoW Lung Cancer Translational Research Award
Funds translational lung cancer research moving toward the clinic, at either a late preclinical stage or a pilot clinical trial.
A lung cancer finding that only ever lives in a lab does not help anyone — turning a promising idea into something a patient can actually receive is its own separate, harder problem.
This award funds advanced translational lung cancer research aimed at moving a promising idea toward clinical application, tied to one of the year's Lung Cancer Research Program areas of emphasis.
Applications go in…
Advanced translational lung cancer research moving a promising finding toward clinical application, tied to a named FY26 Lung Cancer Research Program area of emphasis, at either Funding Level 1 (advanced preclinical or correlative work) or Funding Level 2 (pilot clinical trials of a novel intervention).
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up